Introduction to the topic
Dr Beate Wieseler
Criteria for checking the applicability of study results
PD Dr Ulrich Grouven
Approval studies and therapeutic indication - experience from the early benefit assessment
Dr Thomas Kaiser
From clinical data to therapeutic indication – a compass for the benefit assessment?
Dr Karl Broich
New drugs between approval and benefit assessment – how do manufacturers manage?
Professor Dr Torsten Strohmeyer
Importance of approval status for G-BA decisions